Cargando…

Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy

Mutations in the human ether-à-go-go-related gene (hERG) are responsible for long-QT syndrome (LQTS) type 2 (LQT2). In the present study, a heterozygous missense mutation (A561V) linked to LQT2, syncope and epilepsy was identified in the S5/pore region of the hERG protein. The mutation, A561V, was p...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, GUOLIANG, SHI, RUI, WU, JINE, HAN, WENQI, ZHANG, AIFENG, CHENG, GONG, XUE, XIAOLIN, SUN, CHAOFENG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768985/ https://www.ncbi.nlm.nih.gov/pubmed/26847485 http://dx.doi.org/10.3892/mmr.2016.4859

Ejemplares similares

hERG channel function: beyond long QT
por: Babcock, Joseph J, et al.
Publicado: (2013)

hERG1a N-terminal eag domain–containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: A possible mechanism for long QT syndrome
por: Trudeau, Matthew C., et al.
Publicado: (2011)

Isoform-Specific Dominant-Negative Effects Associated with hERG1 G628S Mutation in Long QT Syndrome
por: Stump, Matthew R., et al.
Publicado: (2012)

Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2019)

Pharmacological activation of the hERG K(+) channel for the management of the long QT syndrome: A review
por: El Harchi, Aziza, et al.
Publicado: (2022)

Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2018)

Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation
por: Aromolaran, Ademuyiwa S., et al.
Publicado: (2018)

Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block
por: Tran, Phu N., et al.
Publicado: (2020)

The electric heart of hERG
por: Islas, León D.
Publicado: (2013)

An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020)

hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)

Investigation of PAS and CNBH domain interactions in hERG channels and effects of long-QT syndrome-causing mutations with surface plasmon resonance
por: Soohoo, Stephanie M., et al.
Publicado: (2021)

Long-Chain Acylcarnitines Regulate the hERG Channel
por: Ferro, Fabio, et al.
Publicado: (2012)

The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)

Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients
por: Ono, Makoto, et al.
Publicado: (2020)

Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG ‘hotspot’ mutation
por: Du, Chunyun, et al.
Publicado: (2022)

Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)

Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
por: Lin, Min, et al.
Publicado: (2023)

Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
por: Durdagi, Serdar, et al.
Publicado: (2014)

Structure of the Cyclic Nucleotide-Binding Homology Domain of the hERG Channel and Its Insight into Type 2 Long QT Syndrome
por: Li, Yan, et al.
Publicado: (2016)

Transfer RNA-mediated restoration of potassium current and electrical correction in premature termination long-QT syndrome hERG mutants
por: Blomquist, Viggo G., et al.
Publicado: (2023)

An Insight into the Potassium Currents of hERG and Their Simulation
por: Guidelli, Rolando
Publicado: (2023)

Stereoselective Blockage of Quinidine and Quinine in the hERG Channel and the Effect of Their Rescue Potency on Drug-Induced hERG Trafficking Defect
por: Yan, Meng, et al.
Publicado: (2016)

Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles
por: Whittaker, Dominic G., et al.
Publicado: (2017)

In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome
por: Whittaker, Dominic G., et al.
Publicado: (2019)

The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models
por: Chioccioli Altadonna, Ginevra, et al.
Publicado: (2022)

Increased Vulnerability of Human Ventricle to Re-entrant Excitation in hERG-linked Variant 1 Short QT Syndrome
por: Adeniran, Ismail, et al.
Publicado: (2011)

Action Potential Clamp and Pharmacology of the Variant 1 Short QT Syndrome T618I hERG K(+) Channel
por: El Harchi, Aziza, et al.
Publicado: (2012)

Na(+) Permeation and Block of hERG Potassium Channels
por: Gang, Hongying, et al.
Publicado: (2006)

Stereoselective Inhibition of the hERG1 Potassium Channel
por: Grilo, Liliana Sintra, et al.
Publicado: (2010)

Voltage-Dependent Gating of hERG Potassium Channels
por: Cheng, Yen May, et al.
Publicado: (2012)

Towards a complete structure of the hERG channel
por: Schmidtke, Peter, et al.
Publicado: (2013)

Ion Conduction through the hERG Potassium Channel
por: Ceccarini, Luisa, et al.
Publicado: (2012)

Kv4.3 Modulates the Distribution of hERG
por: Zhao, Xiao-Jing, et al.
Publicado: (2017)

Lipid regulation of hERG1 channel function
por: Miranda, Williams E., et al.
Publicado: (2021)

Trafficking-Deficient G572R-hERG and E637K-hERG Activate Stress and Clearance Pathways in Endoplasmic Reticulum
por: Wang, Ying, et al.
Publicado: (2012)

Support Vector Machine model for hERG inhibitory activities based on the integrated hERG database using descriptor selection by NSGA-II
por: Ogura, Keiji, et al.
Publicado: (2019)

Mitragynine, an euphoric compound inhibits hERG1a/1b channel current and upregulates the complexation of hERG1a-Hsp90 in HEK293-hERG1a/1b cells
por: Tay, Yea Lu, et al.
Publicado: (2019)

R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome
por: Mesquita, Fernanda C. P., et al.
Publicado: (2019)

Development of a High-Throughput Flow Cytometry Assay to Monitor Defective Trafficking and Rescue of Long QT2 Mutant hERG Channels
por: Kanner, Scott A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ovu1drsbrhgvhoql3dtr2rc8p4